dotMD.com
Preventive Screening & Blood Biomarkers • ICD-10-CM T18.9XXA

Bezoar

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM T18.9XXA • 8 Linked .gov / PubMed Citations • Governance: Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Bezoar Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Bezoar

3 of 3 Free Questions Remaining

What Is Bezoar?

Under Preventive Screening & Blood Biomarkers diagnostic criteria (T18.9XXA), workup for Bezoar integrates evidence-based risk stratification in Bezoar (T18.9XXA: pairing lifestyle nutrition/exercise) with evidence-graded therapy tailored to CBC, CMP & in Bezoar (T18.9XXA: eGFR Baseline) response.

Pathophysiology, Underlying Causes & Clinical Presentation

Mechanistic hallmarks of Bezoar (T18.9XXA) center on or micronutrient cofactor in Bezoar (T18.9XXA: reserves years prior). targeted preventive & labs interventions aim to normalize CBC, CMP & in Bezoar (T18.9XXA: eGFR Baseline).

Common Symptoms & Clinical Signs

  • • Presentation of Bezoar (T18.9XXA): subtle fatigue, recovery in Bezoar (T18.9XXA: lag, or micronutrient)
  • • Secondary Bezoar clinical sign: age- or family-history-guided in Bezoar (T18.9XXA: cancer, vascular, bone,)
  • • Symptom flares in Bezoar correlating with CBC, CMP & in Bezoar (T18.9XXA: eGFR Baseline) deviation outside Within optimal preventive reference intervals (T18.9XXA)
  • • Functional preventive & labs impact requiring evidence-based risk stratification in Bezoar (T18.9XXA: pairing lifestyle nutrition/exercise) evaluation (T18.9XXA)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Bezoar Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code T18.9XXA WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub Preventive Screening & Blood Biomarkers NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: CBC, CMP & in Bezoar (T18.9XXA: eGFR Baseline) Within optimal preventive reference intervals (T18.9XXA) Clinical Reference Target Range
Diagnostic / Lab Marker: 25-Hydroxy Vitamin D, in Bezoar (T18.9XXA: Ferritin & B12) 25(OH)D 40–65 ng/mL; Ferritin 50–150 ng/mL (T18.9XXA) Clinical Reference Target Range
Diagnostic / Lab Marker: ApoB, HbA1c & in Bezoar (T18.9XXA: hs-CRP Triad) ApoB < 80 mg/dL; HbA1c < 5.5%; hs-CRP < 1.0 mg/L (T18.9XXA) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Bezoar

Check Drug Interactions →

Treatment selection for Bezoar depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Bezoar)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
New Insights on Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute: What a 344-Participant Study Found

This pooled analysis reinforces the efficacy profile of CTC versus tramadol and, given that CTC permits lower daily tramadol dosing and thereby reduces unnecessary opioid use, this highlights its improved benefit/risk profile...

Drugs in R&D • 2024-06-15 • Phase III Randomized Trial
N = 344 93/100 PMID 38874739 ↗
Can This Approach Help? Inside the Latest Research on Effect of a Single Preventive Intravenous Dose of Ketorolac and Paracetamol on

After septorhinoplasty, the administration of 1000 mg of IV paracetamol demonstrated comparable efficacy in pain reduction to 30 mg of ketorolac.

Iranian journal of medical sciences • 2025-04-15 • Phase III Randomized Trial
N = 33 88/100 PMID 40255229 ↗
Can This Approach Help? Inside the Latest Research on Low-pressure versus standard pressure laparoscopic colorectal surgery (PAROS

Using low-pressure pneumoperitoneum in laparoscopic colonic resection improves postoperative recovery, shortening the duration of hospitalization and decreasing postoperative pain and pain-relieving consumption.

The British journal of surgery • 2021-08-19 • Phase III Randomized Trial
N = 138 88/100 PMID 33755088 ↗
Can This Approach Help? Inside the Latest Research on A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the real-world

Neu-BoNT/A can be effectively and safely used for primary axillary hyperhidrosis.

Aesthetic plastic surgery • 2022-06-15 • Phase III Randomized Trial
Multi-cohort 82/100 PMID 35132458 ↗
Can This Approach Help? Inside the Latest Research on Quality assurance in the randomized multicentre phase III trial

Variations in the delineation of target volumes and organs at risk were frequently judged as "unacceptable" during the RTQA review process.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology • 2025-10-15 • Phase III Randomized Trial
N = 70 82/100 PMID 40796015 ↗
Zero-PHI Patient Support & Cohort Discussions

Bezoar Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Bezoar community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Bezoar.

Related Conditions in Preventive Screening & Blood Biomarkers